Use of an automated capillary DNA sequencer to investigate the interaction of cisplatin with telomeric DNA sequences

Biomedical Chromatography

Volumn 26, Issue 3, 2012, Pages 350-354

  Paul, Moumita ^a   Murray, Vincent ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cisplatin; DNA damage; DNA sequence selectivity; Telomere

Indexed keywords

AUTOMATION; DNA; FLUORESCENCE;

ANTITUMOR DRUGS; CIS-PLATIN; CISPLATIN; DNA DAMAGES; DNA DAMAGING AGENTS; DNA SEQUENCE SELECTIVITY; MECHANISM OF ACTION; SEQUENCE SELECTIVITY; TELOMERES; TELOMERIC DNA;

DNA SEQUENCES;

CISPLATIN; DNA FRAGMENT; FLUORESCENT DYE; PLASMID VECTOR;

ACCURACY; ARTICLE; AUTOMATION; DNA ADDUCT; DNA DAMAGE; DNA SEQUENCE; FLUORESCENCE; GEL; GEL ELECTROPHORESIS; LASER; TELOMERE;

EID: 84856573721     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1664     Document Type: Article

References (25)

1. Adams M, A'Hern RP, Calvert AH, Carmichael J, Clark PI, Coleman RE, Earl HM, Gallagher CJ, Ganesan TS, Gore ME, Graham JD, Harper PG, Jayson GC, Kaye SB, Ledermann JA, Osborne RJ, Perren TJ, Poole CJ, Radford JA, Rustin GJ, Slevin ML, Smyth JF, Thomas H and Wilkinson PM. Chemotherapy for ovarian cancer - a consensus statement on standard practice. British Journal of Cancer 1998; 78: 1404-1406.
2. Akbari A, Marthinsen G, Lifjeld JT, Albregtsen F, Wennerberg L, Stenseth NC and Jakobsen KS. Improved DNA fragment length estimation in capillary electrophoresis. Electrophoresis 2008; 29: 1273-1285.
3. Bando T, Iida H, Tao ZF, Narita A, Fukuda N, Yamori T and Sugiyama H. Sequence specificity, reactivity, and antitumor activity of DNA-alkylating pyrrole-imidazole diamides. Chemical Biology 2003; 10: 751-758.
4. Burstyn JN, Heiger-Bernays WJ, Cohen SM and Lippard SJ. Formation of cis-diamminedichloroplatinum(II) 1, 2-intrastrand cross-links on DNA is flanking-sequence independent. Nucleic Acids Research 2000; 28: 4237-4243.
5. Cairns MJ, Carland M, McFadyen WD, Denny WA and Murray V. The DNA sequence selectivity of maltolato-containing cisplatin analogues in purified plasmid DNA and in intact human cells. Journal of Inorganic Biochemistry 2009; 103: 1151-1155.
6. Deforce DL, Millecamps RE, Van Hoofstat D and Van den Eeckhout EG. Comparison of slab gel electrophoresis and capillary electrophoresis for the detection of the fluorescently labeled polymerase chain reaction products of short tandem repeat fragments. Journal of Chromatography A 1998; 806: 149-155.
7. Einhorn LH. Curing metastatic testicular cancer. Proceedings of the National Academy of Sciences USA 2002; 99: 4592-4595.
8. Einhorn LH and Donohue J. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Annals of Internal Medicine 1977; 87: 293-298.
9. Fichtinger-Schepman AM, van der Veer JL, den Hartog JH, Lohman PH and Reedijk J. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry 1985; 24: 707-713.
10. Fundador EV, Choudhary D, Schenkman JB and Rusling JF. Accurate DNA fragment sizing by capillary electrophoresis with laser-induced fluorescence array for detection of sequence specificity of DNA damage. Analytical Chemistry 2008; 80: 2212-2221.
11. Hardman LC and Murray V. Use of an automated sequencer to determine the sequence specificity of DNA damage. Biochemistry and Molecular Biology International 1997; 42: 349-359.
12. Holland PM, Abramson RD, Watson R and Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5'→3' exonuclease activity of Thermus aquaticus DNA polymerase. Proceedings of the National Academy of Sciences USA 1991; 88: 7276-7280.
13. Ishibashi T and Lippard SJ. Telomere loss in cells treated with cisplatin. Proceedings of the National Academy of Sciences USA 1998; 95: 4219-4223.
14. Jamieson ER and Lippard SJ. Structure, recognition, and processing of cisplatin-DNA adducts. Chemistry Review 1999; 99: 2467-2498.
15. n, present at the telomeres of human chromosomes. Proceedings of the National Academy of Sciences USA 1988; 85: 6622-6626.
16. Murray V. A survey of the sequence-specific interaction of damaging agents with DNA: emphasis on anti-tumour agents. (Review.) Progress in Nucleic Acid Research and Molecular Biology 2000; 63: 367-415.
17. Murray V, Motyka H, England PR, Wickham G, Lee HH, Denny WA and McFadyen WD. An investigation of the sequence-specific interaction of cis-diamminedichloroplatinum(II) and four analogues, including two acridine-tethered complexes, with DNA inside human cells. Biochemistry 1992a; 31: 11812-11817.
18. Murray V, Motyka H, England PR, Wickham G, Lee HH, Denny WA and McFadyen WD. The use of Taq DNA polymerase to determine the sequence specificity of DNA damage caused by cis-diamminedichloroplatinum(II), acridine-tethered platinum(II) diammine complexes or two analogues. The Journal of Biological Chemistry 1992b; 267: 18805-18809.
19. Pinto AL and Lippard SJ. Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA. Biochimica et Biophysica Acta 1985; 780: 167-180.
20. Ponti M, Forrow SM, Souhami RL, D'Incalci M and Hartley JA. Measurement of the sequence specificity of covalent DNA modification by antineoplastic agents using Taq DNA polymerase. Nucleic Acids Research 1991; 19: 2929-2933.
21. Shimizu M, Kosaka N, Shimada T, Nagahata T, Iwasaki H, Nagai H, Shiba T and Emi M. Universal fluorescent labeling (UFL) method for automated microsatellite analysis. DNA Research 2002; 9: 173-178.
22. Temple MD, McFadyen WD, Holmes RJ, Denny WA and Murray V. The interaction of cisplatin and DNA-targeted 9-aminoacridine platinum complexes with DNA. Biochemistry 2000; 39: 5593-5599.
23. Williams SD, Birch R, Einhorn LH, Irwin L, Greco FA and Loehrer PJ. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. The New England Journal of Medicine 1987; 316: 1435-1440.
24. Yindeeyoungyeon W and Schell MA. Footprinting with an automated capillary DNA sequencer. Biotechniques 2000; 29: 1034-1041.
25. Zianni M, Tessanne K, Merighi M, Laguna R and Tabita FR. Identification of the DNA bases of a DNase I footprint by the use of dye primer sequencing on an automated capillary DNA analysis instrument. Journal of Biomolecular Technology 2006; 17: 103-113.